Protalix BioTherapeutics, Inc.
USD2.30
+0.08 (+3.60%)
CEO
Dror Bashan
IPO Date
1998-05-15
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$2.22
Prev. Close
$2.22
Day Low
$2.21
Day High
$2.34
52W Low
$1.36
52W High
$3.19
Market Cap
$0.19B
Volume
1.29M
| 56,000 |
| $1.81 |
| 19 Nov 2025 | Bar-Shalev Amos | director | S-Sale | Disposed | 168 | $1.87 |
| 4 Sept 2025 | Melincoff Gwen A | director | A-Award | Acquired | 7,500 | $0.00 |
| 4 Sept 2025 | Melincoff Gwen A | director | A-Award | Acquired | 15,000 | $1.64 |
| 4 Sept 2025 | Forster Eliot | director | A-Award | Acquired | 7,500 | $0.00 |
| 4 Sept 2025 | Forster Eliot | director | A-Award | Acquired | 15,000 | $1.64 |
| 4 Sept 2025 | Boudes Pol F | director | A-Award | Acquired | 7,500 | $0.00 |
| 4 Sept 2025 | Boudes Pol F | director | A-Award | Acquired | 15,000 | $1.64 |
| 4 Sept 2025 | Elze Christian | director | A-Award | Acquired | 7,500 | $0.00 |